Kenneth T. Mills

Overview

Kenneth T. Mills received an average of $5M in total compensation, including $572K in salary, at Regenxbio from 2016 to 2021.

Source: SEC filings on April 7, 2022 and April 11, 2019.

Related executives

We found six more executives who work or worked at Regenxbio.

Patrick Christmas

Regenxbio

Chief Legal Officer

Vit Vasista

Regenxbio

Chief Financial Officer

Curran Simpson

Regenxbio

EVP, Chief Operations and Technology Officer

Olivier Danos

Regenxbio

Chief Scientific Officer

Vittal Vasista

Regenxbio

Chief Financial Officer

Stephen Yoo

Regenxbio

Chief Medical Officer

News

You may also like